HOMBRE

A randomized controlled trial to compare two approaches to weight loss for overweight and obese Latino men (Hombres con Opciones para Mejorar el Bienestar y bajar el Riesgo de Enfermedades crónicas; men with choices to improve well-being and decrease chronic disease risk)

Lisa G. Rosas, Nan Lv, Kristen M.J. Azar, Lan Xiao, Steven P. Hooker, Megan A. Lewis, Patricia Zavella, Elizabeth M. Venditti, Jun Ma

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Latino men bear a disproportionate burden of obesity, diabetes, and cardiovascular disease.However, limited behavioral lifestyle intervention research has focused on Latino men. This trial compares two approaches to weight loss for overweight and obese Latino men: 1) HOMBRE is a culturally adapted intervention that provides individual choice of either self-directed online videos, coach-facilitated in-person groups, and coach-facilitated online groups; and 2) a minimal intensity intervention that uses online videos with a coach available, if solicited by the participant.Latino men with a Body Mass Index (BMI) of ≥27 kg/m2 and one or more cardiometabolic risk factors (n = 424) will be randomly assigned to receive one of the two approaches.The RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework guides the planned evaluations.The primary aim is to determine the effectiveness of the HOMBRE intervention (the “E” in RE-AIM) on clinically significant weight loss (≥5% of baseline weight) at 18 months. We hypothesize that a significantly higher proportion of HOMBRE participants will maintain ≥5% of weight loss compared with those in the minimal intensity intervention.Secondary aims are to determine the effectiveness of HOMBRE on cardiometabolic risk factors (e.g., blood pressure, waist circumference), health behaviors (e.g., diet and physical activity), and psychosocial well-being (e.g., quality of life and depressive symptoms) and to evaluate the other attributes of RE-AIM. These findings have real word applicability with value to clinicians, patients, and other decision makers considering effective diabetes prevention programs for Latino men in primary care.

Original languageEnglish (US)
Pages (from-to)23-34
Number of pages12
JournalContemporary Clinical Trials
Volume68
DOIs
StatePublished - May 1 2018

Fingerprint

Hispanic Americans
Weight Loss
Chronic Disease
Randomized Controlled Trials
Maintenance
Health Behavior
Waist Circumference
Life Style
Primary Health Care
Body Mass Index
Cardiovascular Diseases
Obesity
Quality of Life
Exercise
Depression
Diet
Blood Pressure
Weights and Measures
Research
Mentoring

Keywords

  • Behavioral lifestyle intervention
  • Cardiometabolic
  • Latino
  • Primary care
  • Technology
  • Weight loss

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

HOMBRE : A randomized controlled trial to compare two approaches to weight loss for overweight and obese Latino men (Hombres con Opciones para Mejorar el Bienestar y bajar el Riesgo de Enfermedades crónicas; men with choices to improve well-being and decrease chronic disease risk). / Rosas, Lisa G.; Lv, Nan; Azar, Kristen M.J.; Xiao, Lan; Hooker, Steven P.; Lewis, Megan A.; Zavella, Patricia; Venditti, Elizabeth M.; Ma, Jun.

In: Contemporary Clinical Trials, Vol. 68, 01.05.2018, p. 23-34.

Research output: Contribution to journalArticle

@article{2734d49952e14e5a8b73d78f5d5678c1,
title = "HOMBRE: A randomized controlled trial to compare two approaches to weight loss for overweight and obese Latino men (Hombres con Opciones para Mejorar el Bienestar y bajar el Riesgo de Enfermedades cr{\'o}nicas; men with choices to improve well-being and decrease chronic disease risk)",
abstract = "Latino men bear a disproportionate burden of obesity, diabetes, and cardiovascular disease.However, limited behavioral lifestyle intervention research has focused on Latino men. This trial compares two approaches to weight loss for overweight and obese Latino men: 1) HOMBRE is a culturally adapted intervention that provides individual choice of either self-directed online videos, coach-facilitated in-person groups, and coach-facilitated online groups; and 2) a minimal intensity intervention that uses online videos with a coach available, if solicited by the participant.Latino men with a Body Mass Index (BMI) of ≥27 kg/m2 and one or more cardiometabolic risk factors (n = 424) will be randomly assigned to receive one of the two approaches.The RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework guides the planned evaluations.The primary aim is to determine the effectiveness of the HOMBRE intervention (the “E” in RE-AIM) on clinically significant weight loss (≥5{\%} of baseline weight) at 18 months. We hypothesize that a significantly higher proportion of HOMBRE participants will maintain ≥5{\%} of weight loss compared with those in the minimal intensity intervention.Secondary aims are to determine the effectiveness of HOMBRE on cardiometabolic risk factors (e.g., blood pressure, waist circumference), health behaviors (e.g., diet and physical activity), and psychosocial well-being (e.g., quality of life and depressive symptoms) and to evaluate the other attributes of RE-AIM. These findings have real word applicability with value to clinicians, patients, and other decision makers considering effective diabetes prevention programs for Latino men in primary care.",
keywords = "Behavioral lifestyle intervention, Cardiometabolic, Latino, Primary care, Technology, Weight loss",
author = "Rosas, {Lisa G.} and Nan Lv and Azar, {Kristen M.J.} and Lan Xiao and Hooker, {Steven P.} and Lewis, {Megan A.} and Patricia Zavella and Venditti, {Elizabeth M.} and Jun Ma",
year = "2018",
month = "5",
day = "1",
doi = "10.1016/j.cct.2018.02.019",
language = "English (US)",
volume = "68",
pages = "23--34",
journal = "Contemporary Clinical Trials",
issn = "1551-7144",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - HOMBRE

T2 - A randomized controlled trial to compare two approaches to weight loss for overweight and obese Latino men (Hombres con Opciones para Mejorar el Bienestar y bajar el Riesgo de Enfermedades crónicas; men with choices to improve well-being and decrease chronic disease risk)

AU - Rosas, Lisa G.

AU - Lv, Nan

AU - Azar, Kristen M.J.

AU - Xiao, Lan

AU - Hooker, Steven P.

AU - Lewis, Megan A.

AU - Zavella, Patricia

AU - Venditti, Elizabeth M.

AU - Ma, Jun

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Latino men bear a disproportionate burden of obesity, diabetes, and cardiovascular disease.However, limited behavioral lifestyle intervention research has focused on Latino men. This trial compares two approaches to weight loss for overweight and obese Latino men: 1) HOMBRE is a culturally adapted intervention that provides individual choice of either self-directed online videos, coach-facilitated in-person groups, and coach-facilitated online groups; and 2) a minimal intensity intervention that uses online videos with a coach available, if solicited by the participant.Latino men with a Body Mass Index (BMI) of ≥27 kg/m2 and one or more cardiometabolic risk factors (n = 424) will be randomly assigned to receive one of the two approaches.The RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework guides the planned evaluations.The primary aim is to determine the effectiveness of the HOMBRE intervention (the “E” in RE-AIM) on clinically significant weight loss (≥5% of baseline weight) at 18 months. We hypothesize that a significantly higher proportion of HOMBRE participants will maintain ≥5% of weight loss compared with those in the minimal intensity intervention.Secondary aims are to determine the effectiveness of HOMBRE on cardiometabolic risk factors (e.g., blood pressure, waist circumference), health behaviors (e.g., diet and physical activity), and psychosocial well-being (e.g., quality of life and depressive symptoms) and to evaluate the other attributes of RE-AIM. These findings have real word applicability with value to clinicians, patients, and other decision makers considering effective diabetes prevention programs for Latino men in primary care.

AB - Latino men bear a disproportionate burden of obesity, diabetes, and cardiovascular disease.However, limited behavioral lifestyle intervention research has focused on Latino men. This trial compares two approaches to weight loss for overweight and obese Latino men: 1) HOMBRE is a culturally adapted intervention that provides individual choice of either self-directed online videos, coach-facilitated in-person groups, and coach-facilitated online groups; and 2) a minimal intensity intervention that uses online videos with a coach available, if solicited by the participant.Latino men with a Body Mass Index (BMI) of ≥27 kg/m2 and one or more cardiometabolic risk factors (n = 424) will be randomly assigned to receive one of the two approaches.The RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework guides the planned evaluations.The primary aim is to determine the effectiveness of the HOMBRE intervention (the “E” in RE-AIM) on clinically significant weight loss (≥5% of baseline weight) at 18 months. We hypothesize that a significantly higher proportion of HOMBRE participants will maintain ≥5% of weight loss compared with those in the minimal intensity intervention.Secondary aims are to determine the effectiveness of HOMBRE on cardiometabolic risk factors (e.g., blood pressure, waist circumference), health behaviors (e.g., diet and physical activity), and psychosocial well-being (e.g., quality of life and depressive symptoms) and to evaluate the other attributes of RE-AIM. These findings have real word applicability with value to clinicians, patients, and other decision makers considering effective diabetes prevention programs for Latino men in primary care.

KW - Behavioral lifestyle intervention

KW - Cardiometabolic

KW - Latino

KW - Primary care

KW - Technology

KW - Weight loss

UR - http://www.scopus.com/inward/record.url?scp=85044131039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044131039&partnerID=8YFLogxK

U2 - 10.1016/j.cct.2018.02.019

DO - 10.1016/j.cct.2018.02.019

M3 - Article

VL - 68

SP - 23

EP - 34

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

SN - 1551-7144

ER -